1. Dang M, Phillips PC. Immunotherapy targets several different pediatric brain tumors. JAMA. 2017;317(17):1715–57.
2. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80.
3. Bell H, Ownsworth T, Lloyd O, Sheeran N, Chambers S. A systematic review of factors related to children’s quality of life and mental health after brain tumor. Psychooncology. 2018;27(10):2317–26.
4. Kyu HH, Stein CE, Boschi Pinto C, Rakovac I, Weber MW, Dannemann Purnat T, et al. Causes of death among children aged 5–14 years in the WHO European region: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Child Adolesc Health. 2018;2(5):321–37.
5. Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, et al. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol. 2005;23(22):5198–204.